GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity

被引:71
作者
Orvieto, Raoul [1 ,2 ]
Meltzer, Simion
Rabinson, Jacob
Zohav, Efraim
Anteby, Eyal Y. [2 ]
Nahum, Ravit
机构
[1] Barzilai Govt Hosp, Dept Obstet & Gynecol, Infertil & Unit F4, IL-78278 Ashqelon, Israel
[2] Ben Gurion Univ Negev, Sch Med, IL-84105 Beer Sheva, Israel
关键词
D O I
10.1016/j.fertnstert.2007.10.022
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
To examine whether the choice of the GnRH analogues used during controlled ovarian hyperstimulation (COH), may influence endometrial receptivity, we studied 712 IVF cycles, in patients undergoing COH with GnRH agonist or antagonist and with the transfer of at least one top-quality embryo. The GnRH agonist group showed significantly higher endometrial thickness and higher pregnancy rate, suggestive of a higher endometrial receptivity, compared with the GnRH antagonist group.
引用
收藏
页码:1294 / 1296
页数:3
相关论文
共 19 条
[1]
GnRH antagonist in assisted reproduction: a Cochrane review [J].
Al-Inany, H ;
Aboulghar, M .
HUMAN REPRODUCTION, 2002, 17 (04) :874-885
[2]
Gonadotrophin-releasing hormone antagonists for assisted conception: A Cochrane Review [J].
Al-Inany, H. G. ;
Abou-Setta, A. M. ;
Aboulghar, M. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 14 (05) :640-649
[3]
Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? [J].
Fauser, BCJM ;
Devroey, P .
FERTILITY AND STERILITY, 2005, 83 (06) :1607-1611
[4]
Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF [J].
Fujii, S ;
Sato, S ;
Fukui, A ;
Kimura, H ;
Kasai, G ;
Saito, Y .
HUMAN REPRODUCTION, 2001, 16 (08) :1671-1675
[5]
Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilization cycle [J].
Gartner, B ;
Moreno, C ;
Marinaro, A ;
Remohí, J ;
Simón, C ;
Pellicer, A .
HUMAN REPRODUCTION, 1997, 12 (11) :2557-2559
[6]
GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry [J].
Griesinger, G ;
Felberbaum, R ;
Diedrich, K .
HUMAN REPRODUCTION, 2005, 20 (09) :2373-2375
[7]
Embryo implantation: the Rubicon for GnRH antagonists [J].
Hernandez, ER .
HUMAN REPRODUCTION, 2000, 15 (06) :1211-1216
[8]
Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol: Meta-analysis [J].
Ludwig M. ;
Katalinic A. ;
Diedrich K. .
Archives of Gynecology and Obstetrics, 2001, 265 (4) :175-182
[9]
Is ovarian stimulation detrimental to the endometrium? [J].
Martinez-Conejero, Jose A. ;
Simon, Carlos ;
Pellicer, Antonio ;
Horcajadas, Jose A. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 15 (01) :45-50
[10]
Orvieto R, 2006, Clin Exp Obstet Gynecol, V33, P197